Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 6/20 | 0.55 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.54 |
| ▸ | NPY1R | P25929 | 3/20 | 0.53 |
| ▸ | NPY2R | P49146 | 3/20 | 0.53 |
| ▸ | NPY4R | P50391 | 3/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.52 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.51 |
| ▸ | GLP1R | P43220 | 1/20 | 0.51 |
| ▸ | GCGR | P47871 | 1/20 | 0.51 |
| ▸ | GIPR | P48546 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29388140 | 1.00 | GHSR (0.55) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL3486221 | 0.94 | GHSR (0.61) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL30466124 | 0.94 | GHSR (0.61) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL3486226 | 0.94 | GHSR (0.61) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL29434320 | 0.94 | GHSR (0.61) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL19731345 | 0.92 | KISS1R (0.54) | GHSRKISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL24172454 | 0.90 | IL23R (0.61) | GHSRKISS1RNPY2RIL23RGLP1R | |
| SCHEMBL19731216 | 0.90 | IL23R (0.61) | GHSRKISS1RNPY2RIL23RGLP1R | |
| SCHEMBL16692892 | 0.90 | IL23R (0.61) | GHSRKISS1RNPY2RIL23RGLP1R | |
| SCHEMBL19731206 | 0.90 | IL23R (0.61) | GHSRKISS1RNPY2RIL23RGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024172437-A1 | HYALURONIC ACID DERIVATIVE-WKYMVM CONJUGATE AND USE THEREOF | 주식회사 하이셀텍 | 2024-08-22 | — | — | WO | claimed |
| US-20250388632-A1 | ANNEXIN A1-DERIVED POLYPEPTIDE ANALOGUES | RESOTHER PHARMA AS (DK) | 2025-12-25 | — | — | US | disclosed |
| CN-118891273-A | Annexin A1 derived polypeptide analogs | 雷索特制药股份有限公司 | 2024-11-01 | — | — | CN | disclosed |
| WO-2024172437-A1 | HYALURONIC ACID DERIVATIVE-WKYMVM CONJUGATE AND USE THEREOF | 주식회사 하이셀텍 | 2024-08-22 | — | — | WO | disclosed |
| US-20220133839-A1 | PEPTIDE ANALOGUES WITH BRANCHED AMINO ACID PROBE(S) | TXP PHARMA GMBH (CH) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388632-A1 | ANNEXIN A1-DERIVED POLYPEPTIDE ANALOGUES | ANXA11, ANXA1, ANXA4 | GHSR 2471/4885KISS1R 2957/4885NPY1R 253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.